| 000 | 01606 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514025713.0 | ||
| 264 | 0 | _c20020416 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0939-5555 | ||
| 024 | 7 |
_a10.1007/s00277-001-0397-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGemmel, C | |
| 245 | 0 | 0 |
_aAnti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cFeb 2002 |
||
| 300 |
_a119-23 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Plasma Cell _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aCremer, F W | |
| 700 | 1 | _aWeis, M | |
| 700 | 1 | _aWitzens, M | |
| 700 | 1 | _aMoldenhauer, G | |
| 700 | 1 | _aKoniczek, K-H | |
| 700 | 1 | _aImbach, U | |
| 700 | 1 | _aHo, A D | |
| 700 | 1 | _aMoos, M | |
| 700 | 1 | _aGoldschmidt, H | |
| 773 | 0 |
_tAnnals of hematology _gvol. 81 _gno. 2 _gp. 119-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-001-0397-4 _zAvailable from publisher's website |
| 999 |
_c11813328 _d11813328 |
||